Home
Juha Pekka Kallio's picture

Juha Pekka Kallio

Researcher
  • E-mailJuha.Kallio@uib.no
  • Visitor Address
    Jonas Lies vei 91
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2021). Structure of transmembrane prolyl 4-hydroxylase reveals unique organization of EF and dioxygenase domains. Journal of Biological Chemistry.
  • Show author(s) (2021). Discovery of fungal surface NADases predominantly present in pathogenic species. Nature Communications. 12 pages.
  • Show author(s) (2021). Characterization of porphobilinogen deaminase mutants reveals that arginine-173 is crucial for polypyrrole elongation mechanism. iScience.
  • Show author(s) (2020). Genetic diversity of the flavohemoprotein gene of giardia lamblia: Evidence for high allelic heterozygosity and copy number variation. Infection and Drug Resistance. 4531-4545.
  • Show author(s) (2019). Genetic variation in metronidazole metabolism and oxidative stress pathways in clinical giardia lamblia assemblage A and B isolates. Infection and Drug Resistance. 1221-1235.
  • Show author(s) (2019). A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria. Molecular Therapy.
  • Show author(s) (2018). The quaternary structure of human tyrosine hydroxylase: effects of dystonia‚Äźassociated missense variants on oligomeric state and enzyme activity. Journal of Neurochemistry. 291-306.
  • Show author(s) (2016). Structural and functional dissection of Toxoplasma gondii armadillo repeats only protein. Journal of Cell Science. 1031-1045.
Masters thesis
  • Show author(s) (2022). Biochemical and biophysical characterisation of HMBS variants associated with acute intermittent porphyria.
Errata
  • Show author(s) (2021). Author Correction: Discovery of fungal surface NADases predominantly present in pathogenic species (Nature Communications, (2021), 12, 1, (1631), 10.1038/s41467-021-21307-z). Nature Communications.
Academic literature review
  • Show author(s) (2021). Acute intermittent porphyria: An overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators. International Journal of Molecular Sciences. 25 pages.

More information in national current research information system (CRIStin)

Research groups